Egrifta (generic: tesamorelin) is a prescription medication used to reduce excess abdominal (stomach area) fat in HIV-infected patients with lipodystrophy (increased body fat in certain areas of the body). This medication belongs to a group of drugs called human growth hormone-releasing factor (GRF) analogs. It works by stimulating the synthesis and release of growth hormone which helps break down fatty tissue. 

Egrifta comes in an injectable form to be injected just under the skin (subcutaneously) of the stomach area. It is usually injected once daily.

Common side effects include joint pain, pain in arms and legs, and swelling in the legs.